Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
Recruiting
Who can join
Ages 18 and older · Men
Full eligibility criteria
Inclusion Criteria: * Aged ≥18 years * Male at birth * Identify as a woman/transgender woman * Should not be consistently using PrEP (less than four doses per week) * Should not have any known allergy or adverse reaction to PrEP or the active drug tenofovir in ART. One of the goals of the study is to move more people into a PrEP program * Be able to speak and understand spoken English and/or Spanish (including persons who cannot read or write) * Have a smart phone that can take pictures Exclusion Criteria: * Unwilling to adhere to study procedures * Participation in an HIV vaccine trial * Have a life-threatening SUD\* * Any condition, that in the opinion of the study staff, would make participation in the study unsafe, or interfere with achieving the study objective such as medical conditions which prevents the use of PrEP * Unable to provide consent
About the study
The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their ART treatment.
What is being tested
- Baseline (other)
- ENTRUST (other)
- Control (other)
Sponsor: University of Central Florida · Participants: 110 · Started: Jul 11, 2023
Contact the study team
- Elena Cyrus, PhD · Phone: 4072661507
- Amoy Fraser, PhD, CCRP, PMP · Phone: 4072668742
Official record on ClinicalTrials.gov — NCT06202898
Locations in the U.S.
| Florida | University of Central Florida, Orlando |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.